GRANULES.NS

Granules India Limited [GRANULES.NS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

GRANULES.NS Stock Summary

Top 10 Correlated ETFs

GRANULES.NS

Top 10 Correlated Stocks

GRANULES.NS

In the News

GRANULES.NS Financial details

Company Rating
-
Market Cap
102.24B
Income
3.95B
Revenue
45.26B
Book val./share
-
Cash/share
-
Dividend
1.5
Dividend %
0.37%
Employees
3.65K
Optionable
No
Shortable
Yes
Earnings
14 May 2024
P/E
24.85
Forward P/E
-
PEG
-121.69
P/S
2.17
P/B
3.3
P/C
-
P/FCF
7599.86
Quick Ratio
0.64
Current Ratio
1.35
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
16.31
EPS next Y
-
EPS next Q
-
EPS this Y
26.43%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
17.75%
Revenue last 5Y
15.09%
Revenue Q/Q
-2.85%
EPS Q/Q
23.04%
-
-
-
-
SMA20
-6.07%
SMA50
-17.33%
SMA100
-18.24%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
27%
ROC
0.19%
Gross Margin
50%
Oper. Margin
14%
Profit Margin
9%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
272.35-480.45
52W High
-5.04%
52W Low
+67.57%
RSI
42.49
Rel Volume
0.72
Avg Volume
1.42M
Volume
1.02M
Perf Week
-5.08%
Perf Month
-4.24%
Perf Quarter
-20.06%
Perf Half Y
-17.55%
-
-
-
-
Beta
0.295
-
-
Volatility
12.25%, 20.95%
Prev Close
0.04%
Price
455.8
Change
-1.63%

GRANULES.NS Financial Performance

GRANULES.NS Dividend History

GRANULES.NS Frequently Asked Questions

What is Granules India Limited stock symbol ?

Granules India Limited is a IN stock and trading under the symbol GRANULES.NS

What is Granules India Limited stock quote today ?

Granules India Limited stock price is $455.8 today.

Is Granules India Limited stock public?

Yes, Granules India Limited is a publicly traded company.

Something similar

Top by Market Cap
ABEA.DE
BRK-B
1YD.DE
MSF.DE
AVGO
Top Correlated ETFs
IFED
SHPP
OND
MTUL
LOPP
Top Correlated Stocks
ANANTRAJ.NS
GREAVESCOT.NS
IGARASHI.NS
DCAL.NS
ELGIEQUIP.NS
Similar Market Cap
ALKYLAMINE.NS
8987.T
600674.SS
GPSC-R.BK
014160.KS

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 1.42M
  • Market Capitalization 102.24B
  • Employee 3.65K
  • CEO Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D.
  • Headquarters Hyderabad,IN
  • IPO Date 2005-06-20
  • Website https://www.granulesindia.com

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.